Evidence map›Paper›PMID 17145369›Full record

ArticleHuman immunology2006

Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides.

Daniel Gebreselassie, Hans Spiegel, Stanislav Vukmanovic

Open access · greenAbstract read
In one paragraph

Article in Human immunology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Behçet's Disease: A Comprehensive Review on the Role ofInternational journal of molecular sciences · 2023
    Pooled it
  2. Pooled it
  3. Article
  4. Homotypic and heterotypicCurrent research in immunology · 2022
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Deimmunizing substitutions inThe Journal of biological chemistry · 2019
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. The MHC class I peptide repertoire is molded by the transcriptome.The Journal of experimental medicine · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Daniel GebreselassieCenter for Cancer and Immunology Research, Children's Research Institute, Children's National Medical Center, Washington, DC 20010-2970, USA.
Hans Spiegel
Stanislav Vukmanovic
Children's National · US

Funding

RECEPTOR/LIGAND INTERACTIONS IN T CELL DIFFERENTIATIONR01AI041573 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI VUKMANOVIC, STANISLAV · 1998 to 2007
$1.7M
DYNAMICS OF PERIPHERAL T CELL REPERTOIRER01AI048837 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI VUKMANOVIC, STANISLAV · 2002 to 2006
$1.7M
NIAID NIH HHS AI41573NIAID NIH HHS AI48837NIAID NIH HHS R01 AI041573NIAID NIH HHS R01 AI041573-09NIAID NIH HHS R01 AI048837NIAID NIH HHS R01 AI048837-06
6 · The paper itself

Abstract

We have analyzed peptides associated with six human major histocompatibility complex (MHC) class I allomorphs expressed by the U937 cell line. Peptides were isolated by mild acid elution or by MHC class I immunoprecipitation by using W6/32 monoclonal antibody. Eighty-five peptides were sequenced by mass spectrometry, and their putative binding alleles were assigned using bioinformatic tools. Only three peptides isolated by the two approaches were identical, suggesting that the approaches may yield distinct partially overlapping peptide populations. Mild acid treatment-derived peptides manifested overall characteristics suggestive of relatively lower affinity of binding for MHC class I. Interestingly, a large proportion of putative HLA-B*5101-binding peptides was evident among the mild acid treatment-eluted peptides, and to a lesser degree in the affinity-purified peptide pool. These results suggest that HLA-B*5101 may bind a potentially large pool of peptides with relatively lower affinity. We suggest that lower affinity of peptide binding may be the basis for inefficient tolerance to HLA-B*5101-binding self-peptides, a predisposing factor for the development of Behçet disease.

Indexed as

Amino Acid SequenceBehcet SyndromeBinding SitesHistocompatibility Antigens Class IHLA-B AntigensHumansIntracellular SpaceMass SpectrometryMolecular Sequence DataMolecular WeightPeptidesProtein BindingU937 CellsHistocompatibility Antigens Class IHLA-B AntigensPeptides

Identifiers

PMID17145369
PMCPMC2269730
OpenAlexW2048510007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.